FR15C0044I1 - Vaccin comprenant un pestivirus attenue - Google Patents

Vaccin comprenant un pestivirus attenue

Info

Publication number: FR15C0044I1
Authority: FR; France
Prior art keywords: vaccine; attenuated pestivirus; pestivirus; attenuated
Prior art date: 2004-05-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Vetmedica GmbH

Original Assignee

Boehringer Ingelheim Vetmedica GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-19

Filing date

2015-06-19

Publication date

2015-07-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR15C0044(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-06-19 Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH

2015-07-24 Publication of FR15C0044I1 publication Critical patent/FR15C0044I1/fr

2016-05-27 Application granted granted Critical

2016-05-27 Publication of FR15C0044I2 publication Critical patent/FR15C0044I2/fr

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Mycology (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR15C0044C 2004-05-19 2015-06-19 Vaccin comprenant un pestivirus attenue Active FR15C0044I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004025452A DE102004025452A1 (de)	2004-05-19	2004-05-19	Vakzine enthaltend BVDV
PCT/EP2005/005377 WO2005111201A1 (fr)	2004-05-19	2005-05-18	Vaccin comprenant un pestivirus attenue

Publications (2)

Publication Number	Publication Date
FR15C0044I1 true FR15C0044I1 (fr)	2015-07-24
FR15C0044I2 FR15C0044I2 (fr)	2016-05-27

Family

ID=34967522

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
FR15C0043C Active FR15C0043I2 (fr)	2004-05-19	2015-06-19	Vaccin comprenant un pestivirus attenue
FR15C0042C Active FR15C0042I2 (fr)	2004-05-19	2015-06-19	Vaccin comprenant un pestivirus attenue
FR15C0044C Active FR15C0044I2 (fr)	2004-05-19	2015-06-19	Vaccin comprenant un pestivirus attenue

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
FR15C0043C Active FR15C0043I2 (fr)	2004-05-19	2015-06-19	Vaccin comprenant un pestivirus attenue
FR15C0042C Active FR15C0042I2 (fr)	2004-05-19	2015-06-19	Vaccin comprenant un pestivirus attenue

Country Status (26)

Country	Link
EP (1)	EP1751276B9 (fr)
JP (2)	JP5006782B2 (fr)
KR (1)	KR100908798B1 (fr)
CN (2)	CN103352030B (fr)
AR (2)	AR049176A1 (fr)
AT (1)	ATE420949T1 (fr)
AU (1)	AU2005243488B2 (fr)
BR (1)	BRPI0510396B1 (fr)
CA (1)	CA2561719C (fr)
CY (4)	CY1109036T1 (fr)
DE (2)	DE102004025452A1 (fr)
DK (1)	DK1751276T5 (fr)
ES (1)	ES2321210T3 (fr)
FR (3)	FR15C0043I2 (fr)
HU (2)	HUS1500033I1 (fr)
LU (3)	LU92747I2 (fr)
ME (1)	ME01119B (fr)
MX (1)	MXPA06013298A (fr)
NL (3)	NL300744I2 (fr)
NZ (1)	NZ552088A (fr)
PL (1)	PL1751276T3 (fr)
PT (1)	PT1751276E (fr)
RS (1)	RS50753B9 (fr)
SI (1)	SI1751276T1 (fr)
UY (1)	UY28905A1 (fr)
WO (1)	WO2005111201A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7179473B2 (en)	1998-06-05	2007-02-20	Boehringer Ingelheim Vetmedica Gmbh	Attenuated pestiviruses
US7135561B2 (en)	2001-09-06	2006-11-14	Boehringer Ingelheim Vetmedica Gmbh	Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) *	2005-11-15	2009-03-12	Boehringer Ingelheim Vetmedica, Inc.	Combination vaccine comprising an attenuated bovine viral diarrhea virus
AR062917A1 (es) *	2006-09-22	2008-12-17	Intervet Int Bv	Nuevo mutante de pestivirus para uso en una vacuna.
AR069087A1 (es)	2007-10-29	2009-12-30	Boehringer Ingelheim Vetmed	Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
UY31930A (es)	2008-06-25	2010-01-29	Boheringer Ingelheim Pharma Kg	Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
WO2010051210A1 (fr)	2008-10-31	2010-05-06	Boehringer Ingelheim Vetmedica, Inc.	Utilisation de divers antigènes y compris des antigènes provenant de mycoplasma bovis dans une composition de vaccin multivalente
US8846054B2 (en)	2009-01-09	2014-09-30	Boehringer Ingelheim Vetmedica, Inc.	Method of treating pregnant cows and/or heifers
UY32570A (es)	2009-04-24	2010-11-30	Boehringer Ingelheim Vetmed	Vacuna viva modificada de mycoplasma bovis mejorada
ES2606605T3 (es) *	2010-09-21	2017-03-24	Intervet International B.V.	Vacuna para el BVDV
JP6589159B2 (ja) *	2014-04-01	2019-10-16	共立製薬株式会社	新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
DK3146042T3 (da) *	2014-05-23	2019-09-30	Boehringer Ingelheim Vetmedica Gmbh	Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop
CN105779499B (zh) *	2016-03-23	2019-11-19	江苏科技大学	重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) *	2017-11-10	2020-10-02	齐鲁动物保健品有限公司	牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) *	2018-04-18	2021-07-13	中国科学院武汉病毒研究所	猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) *	2022-05-24	2023-06-13	中国农业科学院兰州兽医研究所	一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) *	2023-01-11	2024-06-14	青岛大学	小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6168942B1 (en) *	1998-11-10	2001-01-02	Pfizer Inc.	Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (fr) *	1999-11-30	2001-06-06	Boehringer Ingelheim Vetmedica Gmbh	Virus de la diarrhée des bovins surs attenués pour utilisation chez des vaches gravides
CA2363493C (fr) *	2000-11-22	2006-06-06	Xuemei Cao	Virus de la diarrhee virale bovine de formes attenuees
DE10143813A1 (de) *	2001-09-06	2003-04-10	Boehringer Ingelheim Vetmed	Infektiöser Rindervirusdiarrhoe-Virusklon

2004
- 2004-05-19 DE DE102004025452A patent/DE102004025452A1/de not_active Withdrawn
2005
- 2005-05-18 DK DK05741681.0T patent/DK1751276T5/da active
- 2005-05-18 SI SI200530619T patent/SI1751276T1/sl unknown
- 2005-05-18 NZ NZ552088A patent/NZ552088A/en not_active IP Right Cessation
- 2005-05-18 KR KR1020067026800A patent/KR100908798B1/ko not_active Expired - Lifetime
- 2005-05-18 WO PCT/EP2005/005377 patent/WO2005111201A1/fr not_active Ceased
- 2005-05-18 DE DE602005012381T patent/DE602005012381D1/de not_active Expired - Lifetime
- 2005-05-18 AR ARP050102032A patent/AR049176A1/es active IP Right Grant
- 2005-05-18 PL PL05741681T patent/PL1751276T3/pl unknown
- 2005-05-18 BR BRPI0510396-7A patent/BRPI0510396B1/pt active IP Right Grant
- 2005-05-18 CN CN201310269097.1A patent/CN103352030B/zh not_active Expired - Lifetime
- 2005-05-18 MX MXPA06013298A patent/MXPA06013298A/es active IP Right Grant
- 2005-05-18 ES ES05741681T patent/ES2321210T3/es not_active Expired - Lifetime
- 2005-05-18 UY UY28905A patent/UY28905A1/es not_active IP Right Cessation
- 2005-05-18 CN CN200580024345XA patent/CN1989240B/zh not_active Expired - Lifetime
- 2005-05-18 JP JP2007517077A patent/JP5006782B2/ja not_active Expired - Lifetime
- 2005-05-18 ME MEP-2009-56A patent/ME01119B/me unknown
- 2005-05-18 RS RS20090106A patent/RS50753B9/sr unknown
- 2005-05-18 CA CA2561719A patent/CA2561719C/fr not_active Expired - Lifetime
- 2005-05-18 AU AU2005243488A patent/AU2005243488B2/en not_active Expired
- 2005-05-18 EP EP05741681.0A patent/EP1751276B9/fr not_active Expired - Lifetime
- 2005-05-18 PT PT05741681T patent/PT1751276E/pt unknown
- 2005-05-18 AT AT05741681T patent/ATE420949T1/de active
2009
- 2009-04-10 CY CY20091100429T patent/CY1109036T1/el unknown
2011
- 2011-11-11 JP JP2011247652A patent/JP5562316B2/ja not_active Expired - Lifetime
2015
- 2015-06-16 NL NL300744C patent/NL300744I2/nl unknown
- 2015-06-16 NL NL300745C patent/NL300745I1/nl unknown
- 2015-06-16 NL NL300743C patent/NL300743I2/nl unknown
- 2015-06-19 CY CY2015021C patent/CY2015021I2/el unknown
- 2015-06-19 LU LU92747C patent/LU92747I2/fr unknown
- 2015-06-19 LU LU92749C patent/LU92749I2/fr unknown
- 2015-06-19 FR FR15C0043C patent/FR15C0043I2/fr active Active
- 2015-06-19 CY CY2015023C patent/CY2015023I2/el unknown
- 2015-06-19 CY CY2015022C patent/CY2015022I2/el unknown
- 2015-06-19 HU HUS1500033C patent/HUS1500033I1/hu unknown
- 2015-06-19 FR FR15C0042C patent/FR15C0042I2/fr active Active
- 2015-06-19 LU LU92748C patent/LU92748I2/fr unknown
- 2015-06-19 HU HUS1500031 patent/HUS1500031I1/hu unknown
- 2015-06-19 FR FR15C0044C patent/FR15C0044I2/fr active Active
2016
- 2016-04-28 AR ARP160101219A patent/AR104448A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUS1500033I1 (hu)	2015-07-28
CY2015021I2 (el)	2023-11-15
KR20070012862A (ko)	2007-01-29
NL300743I1 (fr)	2016-01-26
CN1989240B (zh)	2013-07-31
JP5006782B2 (ja)	2012-08-22
RS50753B (sr)	2010-08-31
BRPI0510396A (pt)	2007-11-13
CN103352030A (zh)	2013-10-16
CY2015022I1 (el)	2020-05-29
DK1751276T5 (da)	2020-07-20
CA2561719C (fr)	2015-01-27
JP2007537740A (ja)	2007-12-27
CA2561719A1 (fr)	2005-11-24
CN1989240A (zh)	2007-06-27
HUS1500031I1 (hu)	2019-11-28
LU92749I2 (fr)	2015-11-02
NL300744I1 (fr)	2016-01-26
DE102004025452A1 (de)	2006-01-19
ES2321210T9 (es)	2020-11-04
RS50753B9 (sr)	2020-08-31
ATE420949T1 (de)	2009-01-15
ME01119B (me)	2013-03-20
CY2015023I2 (el)	2024-02-16
SI1751276T1 (sl)	2009-06-30
CY1109036T1 (el)	2014-07-02
NL300745I2 (fr)	2016-01-26
AU2005243488B2 (en)	2011-07-07
ES2321210T3 (es)	2009-06-03
FR15C0043I1 (fr)	2015-07-24
FR15C0042I2 (fr)	2018-11-16
UY28905A1 (es)	2005-12-30
WO2005111201A1 (fr)	2005-11-24
NZ552088A (en)	2009-10-30
MXPA06013298A (es)	2007-05-07
LU92747I2 (fr)	2015-11-02
CY2015021I1 (el)	2020-05-29
DK1751276T3 (da)	2009-05-18
PT1751276E (pt)	2009-02-24
EP1751276B1 (fr)	2009-01-14
EP1751276A1 (fr)	2007-02-14
FR15C0042I1 (fr)	2015-07-24
AR049176A1 (es)	2006-07-05
JP5562316B2 (ja)	2014-07-30
NL300743I2 (fr)	2016-01-26
KR100908798B1 (ko)	2009-07-22
BRPI0510396B1 (pt)	2020-08-18
FR15C0043I2 (fr)	2016-05-27
AU2005243488A1 (en)	2005-11-24
DE602005012381D1 (de)	2009-03-05
EP1751276B9 (fr)	2020-05-27
CN103352030B (zh)	2018-08-10
LU92748I2 (fr)	2015-11-02
JP2012061001A (ja)	2012-03-29
CY2015022I2 (el)	2024-02-16
AR104448A2 (es)	2017-07-19
NL300744I2 (fr)	2016-01-26
PL1751276T3 (pl)	2009-06-30
NL300745I1 (fr)	2016-01-26
FR15C0044I2 (fr)	2016-05-27
CY2015023I1 (el)	2020-05-29

Publication	Publication Date	Title
FR15C0044I2 (fr)	2016-05-27	Vaccin comprenant un pestivirus attenue
DK3395396T3 (da)	2020-09-28	Plaster-lignende infusionsindretning
MA28609B1 (fr)	2007-05-02	Vaccins
DK1747036T3 (da)	2011-07-11	Inhalatorindretning
EP1920701A4 (fr)	2009-05-06	Dispositif medical
MA28885B1 (fr)	2007-09-03	vaccins
MA28639B1 (fr)	2007-06-01	Vaccins
NL1028036A1 (nl)	2005-07-18	Weergave-inrichting.
DK1768728T3 (da)	2009-01-19	Tæller til inhalatoranordning
DK1729819T3 (da)	2008-10-20	Indgivelsesanordning til lægemidler, som er röntgenstråle-synlige
NL1028326A1 (nl)	2005-09-08	Beeldgevend tomografieapparaat.
FR2897772B1 (fr)	2010-08-27	Dispositif therapeutique
NL1026326A1 (nl)	2004-12-07	Patient-ligtafel.
EP1922975A4 (fr)	2010-01-20	Dispositif medical
EP1932557A4 (fr)	2010-03-03	Dispositif médical
EP1872794A4 (fr)	2009-07-15	Vaccin nasal
DE502005004299D1 (de)	2008-07-10	Liefergerät
ITTV20040018U1 (it)	2004-07-13	Dispositivo di copertura particolarmente per gambe di scrivanie
FR2865780B1 (fr)	2006-06-02	Dispositif de pompage
DK1604683T3 (da)	2007-06-11	Gangliogsid-baserede vaccinesammensætninger til subkutan administration
AP2709A (en)	2013-07-30	An anti-theileriosis vaccine
NL1028136A1 (nl)	2005-08-01	Spelapparaat-samenstel.
CL2004002202S1 (es)	2005-03-18	Silla. (provisorio)
ITGE20040114A1 (it)	2005-03-17	Procedimento per preparato per farinata ligure.
ES1057161Y (es)	2004-10-16	Dispositivo de juego.